Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer
Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer
Recruiting · NCT04991948 · Registry updated 2022-03-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer | Unresectable Metastatic Colorectal Cancer | Recruiting | Phase 1 | 2022-03-09 | NCT04991948 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Celyad Oncology SA | 4 |
| Merck Sharp & Dohme LLC | 650 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Mayo Clinic | Jacksonville | United States | 122 |
| Moffit Cancer Center | Tampa | United States | 20 |
| UZ Antwerpen | Edegem | Belgium | 32 |
| UZ Gent | Ghent | Belgium | 113 |
| UZ Leuven | Leuven | Belgium | 236 |